Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Other Accumulated Expenses (2021 - 2024)

Opus Genetics (IRD) has disclosed Other Accumulated Expenses for 3 consecutive years, with $43000.0 as the latest value for Q1 2023.

  • On a quarterly basis, Other Accumulated Expenses fell 42.67% to $43000.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $43000.0, a 42.67% decrease, with the full-year FY2022 number at $167000.0, up 108.75% from a year prior.
  • Other Accumulated Expenses was $43000.0 for Q1 2023 at Opus Genetics, down from $167000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $167000.0 in Q4 2022 to a low of $16000.0 in Q2 2021.
  • A 3-year average of $75833.3 and a median of $74500.0 in 2022 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: skyrocketed 108.75% in 2022, then plummeted 42.67% in 2023.
  • Opus Genetics' Other Accumulated Expenses stood at $80000.0 in 2021, then surged by 108.75% to $167000.0 in 2022, then plummeted by 74.25% to $43000.0 in 2023.
  • Per Business Quant, the three most recent readings for IRD's Other Accumulated Expenses are $43000.0 (Q1 2023), $167000.0 (Q4 2022), and $74000.0 (Q3 2022).